In patients, miR-135a inhibits cancer cell proliferation and exhibits the properties of a tumor suppressor in renal-cell carcinoma [39], while its target oncoprotein BAG-1 increases more than 4 fold as determined by proteomics. The gene discussed is BAG1; the disease is cancer.